Neubase Therapeutics Stock Filter Stocks by Fundamentals
NBSEDelisted Stock | USD 1.62 0.17 9.50% |
NeuBase Therapeutics fundamentals help investors to digest information that contributes to NeuBase Therapeutics' financial success or failures. It also enables traders to predict the movement of NeuBase Stock. The fundamental analysis module provides a way to measure NeuBase Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeuBase Therapeutics stock.
NeuBase |
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
All Next | Launch Module |
NeuBase Fundamentals
Return On Equity | -0.93 | |||
Return On Asset | -0.43 | |||
Current Valuation | (5.83 M) | |||
Shares Outstanding | 3.75 M | |||
Shares Owned By Insiders | 13.37 % | |||
Shares Owned By Institutions | 12.68 % | |||
Number Of Shares Shorted | 15.57 K | |||
Price To Earning | (4.17) X | |||
Price To Book | 0.18 X | |||
EBITDA | (32.49 M) | |||
Net Income | (33.78 M) | |||
Cash And Equivalents | 29.85 M | |||
Cash Per Share | 0.93 X | |||
Total Debt | 6 M | |||
Debt To Equity | 0.20 % | |||
Current Ratio | 7.53 X | |||
Book Value Per Share | 2.45 X | |||
Cash Flow From Operations | (29.01 M) | |||
Short Ratio | 0.24 X | |||
Earnings Per Share | (18.60) X | |||
Price To Earnings To Growth | (0.07) X | |||
Target Price | 140.0 | |||
Number Of Employees | 37 | |||
Beta | 0.95 | |||
Market Capitalization | 1.42 M | |||
Total Asset | 32.69 M | |||
Retained Earnings | (102.74 M) | |||
Working Capital | 20.48 M | |||
Current Asset | 4.14 M | |||
Current Liabilities | 1.6 M | |||
Net Asset | 32.69 M |
About NeuBase Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeuBase Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuBase Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuBase Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in NeuBase Stock
If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |